091 The impact of device-assisted therapy initiation on the gut microbiome in Parkinson’s disease

• Michal Lubomski,
• Ryan L Davis,
• Jean Yang,
• Carolyn M Sue,
• Xiangnan Xu,
• Andrew J Holmes

Affiliations

Michal Lubomski

1 Neuroimmunology Clinic, Concord Hospital, University of Sydney, Sydney, New South Wales, Australia

Ryan L Davis

1Department of Neurogenetics, University of Sydney, Australia

Jean Yang

5 Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia

Carolyn M Sue

1Department of Neurogenetics, University of Sydney, Australia

Xiangnan Xu

3School of Mathematics and Statistics. Sydney Precision Bioinformatics, University of Sydney, Camperdown, NSW, Australia

Andrew J Holmes

4School of Life and Environmental Sciences, The Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia